Hotline:86-10-67887855 
简体中文Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved
Release time：2022-11-17 14:16:00
Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml ) has been approved by China SFDA on 23th April 2020. The injection registration certificate No. is H20203173.
Reprint statement: reprint please indicate "source: Wista pharma".
Recommend
-
2022-11-17
Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved
-
2022-11-17Olopatadine hydrochloride tablets has been approved by China SF
-
2022-11-17Nafcillin Sodium for injection has been approved by China SF
-
2022-11-17Luliconazole and posaconazole are launched into market
-
2022-11-17Voriconazole tablets has been approved by China SF
86-10-67887855
Head Office：
Marketing：
Wista Pharmam
86-10-67887855